EGFR and non-small cell lung carcinoma: This systematic review included 26 studies with 3282 NSCLC patients and compared direct sequencing and ARMS in terms of the rate of mutations detected and the associations of detected mutations with clinical outcomes of EGFR TKIs treatment.